Synopsis
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Episodes
-
Complement in Rare Kidney Diseases: Different Diseases With a Common Denominator
29/06/2022 Duration: 31minHow familiar are you with the role of complement pathways in the pathophysiology and management of complement-mediated kidney diseases? Credit available for this activity expires: 6/28/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976176?src=mkm_podcast_addon_976176
-
My Challenges and Hopes for a Better Life With Major Depressive Disorder: The Voice of the Patient
29/06/2022 Duration: 28minDid you know that more than 50% of physicians experience burnout and that burnout can lead to a loss of compassion? Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976001?src=mkm_podcast_addon_976001
-
Obesity Talk (Episode 2): Opportunities for the Use of Novel Anti-Obesity Medications in Clinical Practice?
28/06/2022 Duration: 20minAre you up-to-date regarding benefits of novel anti-obesity drugs in people with obesity? Join Drs Sharma and Macklin to improve your knowledge. Credit available for this activity expires: 6/27/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976164?src=mkm_podcast_addon_976164
-
Optimizing Outcomes With Biologic Therapies in Psoriatic Disease
28/06/2022 Duration: 51minDid you know that we could be undertreating patients with psoriasis? Credit available for this activity expires: 6/24/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976067?src=mkm_podcast_addon_976067
-
Seismic Shifts in Heart Failure Management: How Sodium-Glucose Cotransporter-2 Inhibitors Are Changing How We Treat Our Patients
27/06/2022 Duration: 43minInternational expert faculty discuss how sodium-glucose cotransporter-2 (SGLT2) inhibitors have changed the management of patients with heart failure (HF). Credit available for this activity expires: [06/24/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976002?src=mkm_podcast_addon_976002
-
Targeting Angiopoietin-2: A New Approach in Retinal Diseases
24/06/2022 Duration: 26minCan anything improve anti-vascular epithelial growth factor (anti-VEGF) control of exudation in retinal disease? Learn how targeting the angiopoietin pathway may help. Credit available for this activity expires: 6/23/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975535?src=mkm_podcast_addon_975535
-
How to Assess and Diagnose Food Allergies: Experts Discuss Best Practices and Recent Advancements
23/06/2022 Duration: 34minWith incidence of food-induced anaphylaxis on the increase, are you up to date on how best to diagnose and manage patients with food allergies? Credit available for this activity expires: 6/21/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975719?src=mkm_podcast_addon_975719
-
Advanced Age-Related Macular Degeneration: Assessment, Strategies, and New Therapies
21/06/2022 Duration: 31minDo you know the best imaging modalities to diagnose advanced age-related macular degeneration (AMD) and track its progress? Learn how to assess patients and how to discuss with them what the future may hold. Credit available for this activity expires: 6/17/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975758?src=mkm_podcast_addon_975758
-
Novel Therapies for NSCLC With EGFR Exon 20 Insertions: Practical Pearls for the Clinic
21/06/2022 Duration: 41minAre you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 6/20/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726
-
Extending Horizons With Immune Checkpoint Inhibitors in Small Cell Lung Cancer: 2022 Perspectives
17/06/2022 Duration: 40minPatients with extensive-stage small cell lung cancer (ES-SCLC) have a 10-month survival of 10 months following standard frontline chemotherapy. Join the experts in discussing immune checkpoint inhibitors (ICIs) in patients with SCLC. Credit available for this activity expires: 6/15/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975532?src=mkm_podcast_addon_975532
-
Clinical Perspectives on HER2-Targeted Antibody-Drug Conjugates: Treatment-Related Adverse Events
15/06/2022 Duration: 37minDo you know how to safely manage treatment-related adverse events (TRAEs) associated with human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates (ADCs)? Credit available for this activity expires: 6/14/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975383?src=mkm_podcast_addon_975383
-
International Heart Failure Guidelines and the Latest Data: Out of Complexities, Simplicities Emerge With SGLT2 Inhibitors
14/06/2022 Duration: 33minWhat do the latest guidelines say about HF management? Drs Butler, Bozkurt, and McDonagh discuss. Credit available for this activity expires: 6/13/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975310?src=mkm_podcast_addon_975310
-
Epilepsy and Depression: Early Recognition or Double Trouble?
13/06/2022 Duration: 34minDo you know how and when to screen for depression in people with epilepsy, and when to manage depression and when to refer? Credit available for this activity expires: 6/10/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975275?src=mkm_podcast_addon_975275
-
Addressing the Challenge of Endocrine-Resistant Breast Cancer
02/06/2022 Duration: 37minDid you know that estrogen receptor-positive breast cancer often develops treatment resistance to endocrine therapy? Credit available for this activity expires: 5/31/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974726?src=mkm_podcast_addon_974726
-
Addressing the Challenge of HER2 Heterogeneity in Breast Cancer
01/06/2022 Duration: 34minDid you know that there is a paradigm shift in the definition of human epidermal growth factor receptor 2 (HER2) status in breast cancer? Credit available for this activity expires: 5/31/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974715?src=mkm_podcast_addon_974715
-
Management Strategies to Optimize Outcomes in CKD-aP: A Case-Based Discussion
27/05/2022 Duration: 34minHow well are you managing pruritus in your patients on dialysis? Join this activity to learn about latest developments in chronic kidney disease-associated pruritus (CKD-aP). Credit available for this activity expires: 5/26/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/973462?src=mkm_podcast_addon_973462
-
RSV: Omnipresent and Inescapable
27/05/2022 Duration: 18minDid you know that 3.5 million children are hospitalized each year with a respiratory syncytial virus (RSV) infection, but the true burden is unknown due to a lack of diagnosis? Credit available for this activity expires: 5/26/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974410?src=mkm_podcast_addon_974410
-
The Molecular Tumor Board: Best Practices for Managing Primary and Acquired EGFR TKI Resistance
24/05/2022 Duration: 45minDo you know that primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) occurs in approximately 20% to 30% of patients with EGFR-mutated non-small cell lung cancer (NSCLC), and acquired resistance is inevitable? Credit available for this activity expires: 5/23/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/974097?src=mkm_podcast_addon_974097
-
The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to Treatment?
17/05/2022 Duration: 29minDrs Zieroth and Anker discuss heart failure (HF) outcome trials with sodium-glucose cotransporter-2 (SGLT2) inhibitors. Credit available for this activity expires: 5/17/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972924?src=mkm_podcast_addon_972924
-
Managing Psoriatic Disease With Biologic Therapies
12/05/2022 Duration: 35minDid you know that over the past years, the percentage of patients who report entheseal involvement in clinical studies has almost doubled from approximately 30% to 60%? Credit available for this activity expires: 5/10/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/973518?src=mkm_podcast_addon_973518